Wen-Jin Cherng Selected Research

Ergonovine (Ergometrine)

5/2008	Role of coronary spasm for a positive noninvasive stress test result in angina pectoris patients without hemodynamically significant coronary artery disease.
9/2007	Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
4/2007	Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease.
5/2004	Provocation of coronary vasospastic angina using an isoproterenol head-up tilt test.
8/2002	Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Jin Cherng Research Topics

Disease

8	Myocardial Infarction 01/2020 - 07/2006
8	Coronary Artery Disease (Coronary Atherosclerosis) 05/2013 - 08/2002
8	Coronary Vasospasm (Coronary Artery Vasospasm) 12/2010 - 08/2002
6	Heart Failure 01/2020 - 01/2012
5	Diabetes Mellitus 01/2020 - 12/2006
5	Inflammation (Inflammations) 07/2013 - 08/2005
4	Ischemic Stroke 01/2020 - 07/2015
4	Acute Coronary Syndrome 01/2020 - 08/2002
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 07/2015
4	Ischemia 03/2012 - 07/2006
4	Hypertension (High Blood Pressure) 01/2012 - 10/2008
4	Angina Pectoris 09/2007 - 01/2005
3	Chronic Renal Insufficiency 12/2018 - 07/2010
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2013 - 05/2006
3	Hyperplasia 01/2012 - 03/2007
2	Stroke (Strokes) 01/2020 - 01/2016
2	Cardiogenic Shock 01/2019 - 07/2016
2	Hemorrhagic Stroke 12/2018 - 07/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2013 - 07/2008
2	Vascular Diseases (Vascular Disease) 04/2013 - 08/2005
2	Atherosclerosis 05/2010 - 07/2008
2	Chest Pain (Chest Pains) 05/2008 - 04/2007
2	Neointima 01/2008 - 03/2004
2	Coronary Stenosis (Coronary Artery Stenosis) 03/2006 - 08/2002
1	Hypotension (Low Blood Pressure) 12/2021
1	Body Weight (Weight, Body) 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Dyspnea (Shortness of Breath) 07/2019
1	Cardiotoxicity 05/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019
1	Macular Edema 01/2019
1	Retinal Detachment (Retinal Detachments) 01/2019
1	Ulcer 01/2019
1	Vitreous Hemorrhage 01/2019
1	Diabetic Foot 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Cardio-Renal Syndrome 01/2018
1	Necrosis 07/2016
1	Reperfusion Injury 07/2016
1	Ventricular Remodeling 03/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2013
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2012

Drug/Important Bio-Agent (IBA)

6	C-Reactive ProteinIBA 12/2010 - 01/2005
5	Hemoglobins (Hemoglobin)IBA 01/2020 - 03/2010
5	Ergonovine (Ergometrine)IBA 05/2008 - 08/2002
4	Interleukin-6 (Interleukin 6)IBA 07/2013 - 05/2006
4	CytokinesIBA 05/2011 - 03/2008
3	Oxygen (Dioxygen)IBA 05/2019 - 01/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2016
2	Sitagliptin Phosphate (Januvia)FDA Link 12/2018 - 07/2015
2	MetalsIBA 07/2016 - 01/2016
2	LipidsIBA 01/2016 - 12/2006
2	erucylphosphocholineIBA 11/2013 - 03/2008
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2013 - 05/2012
2	Proteins (Proteins, Gene)FDA Link 04/2013 - 08/2012
2	aliskiren FDA Link 03/2013 - 03/2012
2	AlbuminsIBA 05/2012 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2010 - 08/2005
2	CalciumIBA 03/2006 - 01/2005
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	VildagliptinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	GoldIBA 01/2018
1	Evans Blue (Blue, Evans)FDA Link 07/2016
1	triphenyltetrazoliumIBA 07/2016
1	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 01/2016
1	Atorvastatin (Lipitor)FDA Link 01/2016
1	Ezetimibe (Zetia)FDA Link 01/2016
1	Simvastatin (Zocor)FDA LinkGeneric 01/2016
1	Peroxidase (Myeloperoxidase)IBA 07/2013
1	P-SelectinIBA 05/2013
1	NucleotidesIBA 04/2013
1	Adenosine Triphosphate (ATP)IBA 04/2013
1	Phospholipases A2 (Phospholipase A2)IBA 04/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2013
1	Purinergic P2 Receptors (ADP Receptor)IBA 04/2013
1	salicylhydroxamic acid (SHAM)IBA 03/2013
1	Renin InhibitorsIBA 03/2013
1	AnticoagulantsIBA 01/2013
1	carbonic anhydrase XIIIBA 08/2012
1	LDL Receptors (LDL Receptor)IBA 08/2012
1	carboxypeptidase MIBA 08/2012

Therapy/Procedure

6	Therapeutics 05/2019 - 01/2008
4	Stents 01/2019 - 01/2012
4	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2013 - 01/2008
2	Renal Dialysis (Hemodialysis) 12/2021 - 07/2010
2	Lasers (Laser) 01/2019 - 01/2018
2	Drug-Eluting Stents 07/2016 - 01/2016
2	Ligation 07/2016 - 03/2013
1	Length of Stay 07/2019
1	Noninvasive Ventilation 05/2019
1	Drug Therapy (Chemotherapy) 05/2019
1	Subacute Care 05/2019
1	Vitrectomy 01/2019
1	Intravitreal Injections 01/2019
1	Activities of Daily Living (ADL) 06/2014